Published

Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Emerging Trends in Drugs Addictions and Health
Date: 2024-12-01
Source: OpenAlex
DOI: 10.1016/j.etdah.2023.100109
PubMed: Unavailable

Authors

Eline Pottie G.C. Glatfelter M.H. Baumann Christophe P. Stove

Watch author

Derived topics and classifications

psilocin Pharmacology Mechanism of Action Receptor Pharmacology In Vitro Study Toxicity In Vitro Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor2024-12-01

Related papers

The Psychedelic,-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors.ACS pharmacology & translational science · 2023-10-13